UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000052900 |
|---|---|
| Receipt number | R000060358 |
| Scientific Title | Investigation of how the intramuscular lumbar square muscle block spreads: the Cadaver study |
| Date of disclosure of the study information | 2023/11/26 |
| Last modified on | 2023/11/25 11:30:32 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Investigation of how the intramuscular lumbar square muscle block spreads: the Cadaver study
Acronym
Investigation of how the intramuscular lumbar square muscle block spreads: the Cadaver study
Scientific Title
Investigation of how the intramuscular lumbar square muscle block spreads: the Cadaver study
Scientific Title:Acronym
Investigation of how the intramuscular lumbar square muscle block spreads: the Cadaver study
Region
| Japan |
Condition
Condition
intramuscular lumbar square muscle block spreads
Classification by specialty
| Anesthesiology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
The purpose of this study is to elucidate the spread of the drug solution by performing QLBi in Cadaver. In particular, we will examine the spread of the drug to the posterior branches of the spinal nerves, which play an important role in spinal surgery analgesia.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Confirmatory
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
After performing QLBi in Cadaver, check for spread of staining to posterior branches of spinal nerves.
Key secondary outcomes
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
The donors who have agreed and donated their bodies through the Fukushima Medical University Shiragikikukai donation procedure are eligible for this program.
Key exclusion criteria
None
Target sample size
Research contact person
Name of lead principal investigator
| 1st name | Shiori |
| Middle name | |
| Last name | Tanaka |
Organization
Fukushima Medical University
Division name
Department of Anesthesiology
Zip code
960-1295
Address
1 Hikarigaoka, Fukushima City, Fukushima Prefecture
TEL
0245471342
t-shiori@fmu.ac.jp
Public contact
Name of contact person
| 1st name | Shiori |
| Middle name | |
| Last name | Tanaka |
Organization
Fukushima Medical University
Division name
Department of Anesthesiology
Zip code
960-1295
Address
1 Hikarigaoka, Fukushima City, Fukushima Prefecture
TEL
0245471342
Homepage URL
t-shiori@fmu.ac.jp
Sponsor or person
Institute
Fukushima Medical University
Institute
Department
Personal name
Funding Source
Organization
Fukushima Medical University
Organization
Division
Category of Funding Organization
Non profit foundation
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Fukushima Medical University
Address
1 Hikarigaoka, Fukushima City, Fukushima Prefecture
Tel
0245471342
t-shiori@fmu.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2023 | Year | 11 | Month | 26 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2023 | Year | 11 | Month | 22 | Day |
Date of IRB
Anticipated trial start date
| 2023 | Year | 11 | Month | 26 | Day |
Last follow-up date
| 2024 | Year | 01 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
The purpose of this study is to elucidate the spread of the drug solution by performing QLBi in Cadaver. In particular, we will examine the spread of the drug to the posterior branches of the spinal nerves, which play an important role in spinal surgery analgesia.
Management information
Registered date
| 2023 | Year | 11 | Month | 25 | Day |
Last modified on
| 2023 | Year | 11 | Month | 25 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060358
